Skip to Content

R 533 (Divalproex Sodium Extended-Release 250 mg)

Pill with imprint R 533 is White, Round and has been identified as Divalproex Sodium Extended-Release 250 mg. It is supplied by Dr. Reddy's Laboratories Ltd..

Divalproex sodium is used in the treatment of bipolar disorder; mania; epilepsy; migraine prevention and belongs to the drug class fatty acid derivative anticonvulsants. When treating epilepsy and manic episodes associated with bipolar disorder: There is positive evidence of human fetal risk during pregnancy. When treating migraine: Not for use in pregnancy. Divalproex sodium 250 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for R 533

Divalproex sodium extended-release 250 mg R 533 Front
Divalproex sodium extended-release 250 mg R 533 Back
Divalproex sodium extended-release 250 mg R 533
Divalproex sodium extended-release 250 mg R 533

Divalproex Sodium Extended-Release

Imprint
R 533
Strength
250 mg
Color
White
Shape
Round
Availability
Prescription only
Drug Class
Fatty acid derivative anticonvulsants
Pregnancy Category
D - Positive evidence of risk - When treating epilepsy and manic episodes associated with bipolar disorder, X - Not for use in pregnancy - When treating migraine
CSA Schedule
Not a controlled drug
Labeler / Supplier
Dr. Reddy's Laboratories Ltd.
Inactive Ingredients
hypromelloses, hydroxyethyl cellulose (2000 cps at 1%), lactose monohydrate, microcrystalline cellulose, silicon dioxide, titanium dioxide, polyethylene glycol 400

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC CodeLabeler / Repackager
55111-0533 Dr. Reddy's Laboratories, Inc.
00904-6363 Major Pharmaceuticals

Get help with Imprint Code FAQs.

Related Images for "R 533"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.